Corrigendum: Dawn of chimeric antigen receptor T cell therapy in non-Hodgkin Lymphoma

Karlo Perica, M. Lia Palomba, Renier J. Brentjens
{"title":"Corrigendum: Dawn of chimeric antigen receptor T cell therapy in non-Hodgkin Lymphoma","authors":"Karlo Perica,&nbsp;M. Lia Palomba,&nbsp;Renier J. Brentjens","doi":"10.1002/acg2.44","DOIUrl":null,"url":null,"abstract":"<p>The above paper<sup>1</sup> was published in Volume 1 Issue 3 of <i>Advances in Cell and Gene Therapy</i>. The authors have identified an error in the Introduction which they would like to amend.</p><p>In the final paragraph of page 1, the first sentence “The most common toxicity of CAR therapy is Cytokine Release….” should read “The most common toxicity of CAR therapy is Cytokine Release Syndrome (CRS),<sup>8,19,20</sup> which manifests on a spectrum from mild fever to severe multi-organ dysfunction requiring intensive care.”</p><p>The authors apologize for the error.</p>","PeriodicalId":72084,"journal":{"name":"Advances in cell and gene therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/acg2.44","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in cell and gene therapy","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/acg2.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The above paper1 was published in Volume 1 Issue 3 of Advances in Cell and Gene Therapy. The authors have identified an error in the Introduction which they would like to amend.

In the final paragraph of page 1, the first sentence “The most common toxicity of CAR therapy is Cytokine Release….” should read “The most common toxicity of CAR therapy is Cytokine Release Syndrome (CRS),8,19,20 which manifests on a spectrum from mild fever to severe multi-organ dysfunction requiring intensive care.”

The authors apologize for the error.

勘误:嵌合抗原受体T细胞治疗非霍奇金淋巴瘤的曙光
上述论文1发表在《细胞与基因治疗进展》第1卷第3期。作者在引言中发现了一个错误,他们希望对其进行修改。在第1页的最后一段中,第一句“CAR疗法最常见的毒性是细胞因子释放……”应改为“CAR治疗最常见的毒素是细胞因子分泌综合征(CRS),8,19,20,表现为从轻度发烧到需要重症监护的严重多器官功能障碍。”作者对错误表示歉意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信